All Relations between Narcolepsy and nt1

Publication Sentence Publish Date Extraction Date Species
Niels Christian Haubjerg Østerby, Lone Baandrup, Poul Jørgen Jennu. Psychiatric comorbidity in Danish patients with narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a case-control study. Sleep advances : a journal of the Sleep Research Society. vol 5. issue 1. 2024-10-21. PMID:39430232. to examine the difference in psychiatric comorbidity of danish patients with narcolepsy type 1 (nt1), narcolepsy type 2 (nt2), and idiopathic hypersomnia (ih). 2024-10-21 2024-10-23 Not clear
Pengxin Hu, Yuqing Yuan, Yu Zou, Ruifang Xiong, Jiankun Dai, Xihai Zhao, Liang Xie, Xiaoping Tan. Alterations in the DTI-ALPS index and choroid plexus volume are associated with clinical symptoms in participants with narcolepsy type 1. Sleep medicine. vol 124. 2024-10-20. PMID:39427503. narcolepsy type 1 (nt1) is a sleep disorder characterized by excessive daytime sleepiness accompanied by cataplexy. 2024-10-20 2024-10-23 human
Gillian Heckler, Jennifer Worhach, Grace Wang, Klara Szilagyi, Bo Zhang, Cecilia Diniz Behn, Thomas Scammell, Kiran Mask. Characterizing disrupted nighttime sleep and associated functional outcomes in youth with narcolepsy type 1. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-10-17. PMID:39415540. disrupted nighttime sleep (dns) and sleep instability are common in children and adolescents with narcolepsy type 1 (nt1), but optimal objective sleep measures have not been determined. 2024-10-17 2024-10-19 Not clear
Merve Aktan Suzgun, Elena S Wenz, Julia van der Meer, Livia G Fregolente, Jan D Warncke, Silvia Miano, Jens Acker, Mathias Strub, Elisabeth Olliges, Ramin Khatami, Markus H Schmidt, Claudio L A Bassetti, Sigrid von Manitiu. International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (iSPHYNCS): the impact of psychiatric comorbidities on daily life in central disorders of hypersomnolence-a vicious circle. Journal of sleep research. 2024-10-16. PMID:39410793. presence of psychiatric comorbidities is well documented in narcolepsy type-1 (nt1) but there are limited data on patients with 'other central disorders of hypersomnolence' (och). 2024-10-16 2024-10-18 human
Louise Hjuler Andersen, Andreas Brink-Kjaer, Oliver Sum-Ping, Fabio Pizza, Francesco Biscarini, Niels Christian Haubjerg Østerby, Emmanuel Mignot, Giuseppe Plazzi, Poul J Jennu. Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders. Sleep. 2024-10-11. PMID:39392922. this study aimed to identify novel markers of narcolepsy type 1 (nt1) using between-nap opportunity periods ('lights on') and in-nap opportunity periods ('lights off') features of multiple sleep latency test (mslt) recordings. 2024-10-11 2024-10-14 Not clear
Louise Hjuler Andersen, Andreas Brink-Kjaer, Oliver Sum-Ping, Fabio Pizza, Francesco Biscarini, Niels Christian Haubjerg Østerby, Emmanuel Mignot, Giuseppe Plazzi, Poul J Jennu. Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders. Sleep. 2024-10-11. PMID:39392922. further, we explored if mslts from nt1 and narcolepsy type 2 (nt2) patients could be distinguished despite having the same diagnostic thresholds. 2024-10-11 2024-10-14 Not clear
Mengmeng Wang, Huanhuan Wang, Zhaoyan Feng, Shuai Wu, Bei Li, Fang Han, Fulong Xia. Predicting Depression Among Chinese Patients with Narcolepsy Type 1: A Machine-Learning Approach. Nature and science of sleep. vol 16. 2024-09-25. PMID:39318394. depression is a common psychiatric issue among patients with narcolepsy type 1 (nt1). 2024-09-25 2024-09-27 Not clear
Francesco Biscarini, Chiara Bassi, Marco Menchetti, Corrado Zenesini, Valentina Baldini, Christian Franceschini, Giorgia Varallo, Elena Antelmi, Luca Vignatelli, Fabio Pizza, Giuseppe Plazzi, Francesca Ingravall. Co-occurrence of anxiety and depressive symptoms, suicidal thoughts, and hopelessness in patients with narcolepsy type 1. Sleep medicine. vol 124. 2024-09-19. PMID:39298876. to assesses the prevalence and co-occurrence of anxiety, depressive symptoms, suicidal thoughts, and hopelessness in patients with narcolepsy type 1 (nt1). 2024-09-19 2024-09-22 Not clear
Matteo Conti, Flavia Cirillo, Silvia Maio, Mariana Fernandes, Roberta Bovenzi, Fabio Placidi, Francesca Izzi, Nicola Biagio Mercuri, Claudio Liguor. Increased neutrophil to lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-09-19. PMID:39297540. narcolepsy type 1 (nt1) is an autoimmune disease caused by the selective attack of orexin-producing neurons. 2024-09-19 2024-09-26 Not clear
Lauren Daley, Prabhjyot Saini, Harrison Watters, Yasmine Bassil, Eric Schumacher, Lynn Marie Trotti, Shella Keilhol. Altered functional connectivity and spatiotemporal dynamics in individuals with sleep disorders. bioRxiv : the preprint server for biology. 2024-09-11. PMID:39257828. this study examines the observed functional connectivity in patients with ih, and patients with narcolepsy type 1 (nt1) against healthy control individuals. 2024-09-11 2024-09-13 human
Marieke Vringer, Jingru Zhou, Jari K Gool, Denise Bijlenga, Gert Jan Lammers, Rolf Fronczek, Mink S Schinkelshoe. Recent insights into the pathophysiology of narcolepsy type 1. Sleep medicine reviews. vol 78. 2024-09-06. PMID:39241492. narcolepsy type 1 (nt1) is a sleep-wake disorder in which people typically experience excessive daytime sleepiness, cataplexy and other sleep-wake disturbances impairing daily life activities. 2024-09-06 2024-09-10 Not clear
Kayo Mitsukawa, Michiko Terada, Ryuji Yamada, Taku Monjo, Tetsuaki Hiyoshi, Masanori Nakakariya, Yuichi Kajita, Tatsuya Ando, Tatsuki Koike, Haruhide Kimur. TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models. Scientific reports. vol 14. issue 1. 2024-09-06. PMID:39242684. narcolepsy type 1 (nt1) is associated with severe loss of orexin neurons and characterized by symptoms including excessive daytime sleepiness and cataplexy. 2024-09-06 2024-09-10 mouse
Jiaqin Yu, Ting Shen, Zongshan Li, Tian Lv, Lisan Zhan. Immune Reconstitution Inflammatory Syndrome Due to HIV Treatment as a Potential Trigger: A Case Report with Late-Onset Narcolepsy. Nature and science of sleep. vol 16. 2024-08-20. PMID:39161889. narcolepsy type 1 (nt1) is a unique central sleepiness disorder that affects individuals with excessive daytime sleepiness (eds), cataplexy, sleep paralysis, and hypnagogic hallucinations. 2024-08-20 2024-08-22 human
Andrea Bacelar, Oscar Fernandez, Eduardo Paradella, Raimundo Nonato Rodrigues, Claudia Roberta de Castro Moreno, Regina Alvareng. Association between human leukocyte antigen class II-DR-DQ and narcolepsy: a case control study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-08-16. PMID:39150697. we investigated the association of hla class ii-dr-dq alleles in a sample of patients with narcolepsy-cataplexy (narcolepsy type 1; nt1) and patients with narcolepsy without cataplexy (narcolepsy type 2; nt2) with a control group. 2024-08-16 2024-08-18 human
Maxime Grenot, Alexis Roman, Villalba Manon, Anne-Laure Morel, Fort Patrice, Sebastien Arthaud, Paul-Antoine Libourel, Peyron Christell. Major Alteration Of Motor Control During Rem Sleep In Mice Models Of Sleep Disorders. Sleep. 2024-08-09. PMID:39121093. alteration of motor control during rem sleep has been extensively described in sleep disorders, in particular in isolated rem sleep behavior disorder (irbd) and narcolepsy type 1 (nt1). 2024-08-09 2024-08-12 mouse
Akeem Sanni, Md Abdul Hakim, Mona Goli, Moyinoluwa Adeniyi, Farid Talih, Bartolo Lanuzza, Firas Kobeissy, Giuseppe Plazzi, Monica Moresco, Stefania Mondello, Raffaele Ferri, Yehia Mechre. Serum ACS omega. vol 9. issue 30. 2024-08-05. PMID:39100283. serum the neurological condition known as narcolepsy type 1 (nt1) is an uncommon condition marked by extreme daytime sleepiness, cataplexy, sleep paralysis, hallucinations, disrupted nocturnal sleep, and low or undetectable levels of orexin in the csf fluid. 2024-08-05 2024-08-07 Not clear
Maria Júlia Figueiró Reis, Giselle de Martin Truzzi, Maria Fernanda Naufel, Fernando Morgadinho Santos Coelh. Exploring the association between hypocretin-1 levels and bone mineral content in patients with narcolepsy: A cross-sectional study. Sleep medicine. vol 121. 2024-07-31. PMID:39084148. this study aimed to address anthropometric differences between patients with narcolepsy type 1 (nt1) and type 2 (nt2) and discrepancies in bone mineral content (bmc) as a function of hypocretin-1 (hcrt-1) measured in cerebrospinal fluid (csf). 2024-07-31 2024-08-03 Not clear
Patrizia Congiu, Monica Puligheddu, Agata Maria Capodiferro, Stella Giulia Falqui, Ludovica Tamburrino, Michela Figorilli, Giuseppe Plazzi, Antonella Gaglian. Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders. Sleep medicine. vol 121. 2024-07-30. PMID:39079372. narcolepsy with cataplexy (nt1) is a rare hypothalamic disorder that presents with a dysregulation of the sleep-wake cycle (i.e., excessive daytime sleepiness and sleep and cataplectic attacks) and other motor, cognitive, psychiatric, metabolic, and autonomic disturbances, with putative autoimmune pathogenesis. 2024-07-30 2024-08-02 Not clear
Yuqing Yuan, Xianhui Zhong, Qingqing Zhan, Tiantian Yin, Chengxin Ku, Yuxin Liu, Ziyi Yao, Fen Wang, Yongmin Ding, Liying Deng, Qing Ke, Liang Xi. Association between cytokines and symptoms of depression and anxiety in patients with type 1 narcolepsy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 126. 2024-07-28. PMID:39068820. earlier studies have shown that narcolepsy type 1 (nt1) is an autoimmune inflammatory disease and symptoms of depression and anxiety are closely related to fluctuations in inflammatory cytokines. 2024-07-28 2024-08-02 Not clear
Ee-Rah Sung, Caroline B Maness, Jesse D Cook, Ana Maria Vascan, Danielle Moron, Prabhjyot Saini, David B Rye, David T Plante, Lynn Marie Trott. Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolence. Sleep medicine. vol 121. 2024-07-27. PMID:39067151. we evaluated the performance of the sleep inertia questionnaire (siq) in cdh, and how well it distinguished hypersomnolent groups from controls, and ih (idiopathic hypersomnia) from narcolepsy type 1 (nt1). 2024-07-27 2024-08-02 Not clear